PDB-1mnt: SOLUTION STRUCTURE OF DIMERIC MNT REPRESSOR (1-76)

Basic information

• Entry: Database: PDB / ID: 1mnt
• Title: SOLUTION STRUCTURE OF DIMERIC MNT REPRESSOR (1-76)
• Components: MNT REPRESSOR
• Keywords: TRANSCRIPTION REGULATION

Function / homology

Function:

regulation of DNA-templated transcription / DNA binding

Domain/homology:

Bacteriophage P22, Mnt / Regulatory protein Mnt / Arc-like DNA binding domain / Arc-like DNA binding domain / Met repressor-like / Arc Repressor Mutant / Arc-type ribbon-helix-helix / Ribbon-helix-helix / Orthogonal Bundle / Mainly Alpha

Component:

Regulatory protein mnt

• Biological species: Enterobacteria phage P22 (virus)
• Method: SOLUTION NMR
• Authors: Burgering, M.J.M. / Boelens, R. / Gilbert, D.E. / Breg, J.N. / Knight, K.L. / Sauer, R.T. / Kaptein, R.

Citation

Journal: Biochemistry / Year: 1994
Title: Solution structure of dimeric Mnt repressor (1-76).
Authors: Burgering, M.J. / Boelens, R. / Gilbert, D.E. / Breg, J.N. / Knight, K.L. / Sauer, R.T. / Kaptein, R.

#1: Journal: J.Biomol.NMR / Year: 1993
Title: Observation of Inter-Subunit Noes in a Dimeric P22 Mnt Repressor Mutant by a Time-Shared [15N, 13C] Double Half Filter Technique
Authors: Burgering, M.J.M. / Boelens, R. / Kaptein, R.

#2: Journal: Nature / Year: 1990
Title: Structure of Arc Repressor in Solution: Evidence for a Family of B-Sheet DNA-Binding Protein
Authors: Breg, J.N. / Van Opheusden, J.H.J. / Burgering, M.J.M. / Boelens, R. / Kaptein, R.

#3: Journal: Biochemistry / Year: 1988
Title: The Mnt Repressor of Bacteriophage P22: Role of the C-Terminal Residues in Operator Binding and Tetramer Formation
Authors: Knight, K.L. / Sauer, R.T.

History

Deposition	Jun 28, 1994	Processing site: BNL
Revision 1.0	Sep 30, 1994	Provider: repository / Type: Initial release
Revision 1.1	Mar 24, 2008	Group: Version format compliance
Revision 1.2	Jul 13, 2011	Group: Version format compliance
Revision 1.3	Feb 23, 2022	Group: Database references / Derived calculations / Other Category: database_2 / pdbx_database_status / pdbx_struct_assembly / pdbx_struct_oper_list Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession / _pdbx_database_status.process_site
Revision 1.4	May 22, 2024	Group: Data collection / Category: chem_comp_atom / chem_comp_bond

Assembly

Deposited unit

A: MNT REPRESSOR

B: MNT REPRESSOR

Summary:

• 17.7 kDa, 2 polymers

Component details:

	Theoretical mass	Number of molelcules
Total (without water)	17,652	2
Polymers	17,652	2
Non-polymers	0	0
Water	0	0

1

Summary:

• Idetical with deposited unit
• defined by author

Symmetry operations:

Type	Name	Symmetry operation	Number
identity operation	1_555	x,y,z	1

• Atom site foot note: 1: HIS A 6 - PHE A 7 MODEL 1 OMEGA = 115.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 2: PHE A 9 - ARG A 10 MODEL 1 OMEGA = 239.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 3: PHE A 21 - ARG A 22 MODEL 1 OMEGA = 106.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 4: ALA A 23 - GLU A 24 MODEL 1 OMEGA = 121.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 5: GLU A 24 - ALA A 25 MODEL 1 OMEGA = 24.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 6: ASN A 26 - GLY A 27 MODEL 1 OMEGA = 148.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 7: ARG A 28 - SER A 29 MODEL 1 OMEGA = 241.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 8: SER A 29 - MET A 30 MODEL 1 OMEGA = 214.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 9: ASN A 31 - SER A 32 MODEL 1 OMEGA = 144.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 10: SER A 43 - LYS A 44 MODEL 1 OMEGA = 140.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 11: LYS A 44 - PRO A 45 MODEL 1 OMEGA = 61.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 12: PRO A 45 - SER A 46 MODEL 1 OMEGA = 142.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 13: VAL A 48 - THR A 49 MODEL 1 OMEGA = 347.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 14: THR A 49 - GLY A 50 MODEL 1 OMEGA = 135.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 15: GLY A 50 - TYR A 51 MODEL 1 OMEGA = 353.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 16: ASN A 53 - ASP A 54 MODEL 1 OMEGA = 258.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 17: ALA A 55 - GLU A 56 MODEL 1 OMEGA = 82.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 18: LEU A 58 - ALA A 59 MODEL 1 OMEGA = 141.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 19: PHE B 9 - ARG B 10 MODEL 1 OMEGA = 350.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 20: SER B 29 - MET B 30 MODEL 1 OMEGA = 226.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 21: ASN B 31 - SER B 32 MODEL 1 OMEGA = 141.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 22: SER B 43 - LYS B 44 MODEL 1 OMEGA = 149.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 23: PRO B 45 - SER B 46 MODEL 1 OMEGA = 135.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 24: VAL B 48 - THR B 49 MODEL 1 OMEGA = 357.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 25: ARG B 52 - ASN B 53 MODEL 1 OMEGA = 212.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 26: ASP B 54 - ALA B 55 MODEL 1 OMEGA = 117.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 27: ALA B 55 - GLU B 56 MODEL 1 OMEGA = 137.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 28: LEU B 58 - ALA B 59 MODEL 1 OMEGA = 131.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 29: SER B 63 - GLU B 64 MODEL 1 OMEGA = 119.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 30: GLU B 64 - LEU B 65 MODEL 1 OMEGA = 127.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 31: PHE A 9 - ARG A 10 MODEL 2 OMEGA = 347.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 32: ARG A 16 - GLU A 17 MODEL 2 OMEGA = 121.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 33: SER A 29 - MET A 30 MODEL 2 OMEGA = 216.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 34: ASN A 31 - SER A 32 MODEL 2 OMEGA = 145.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 35: SER A 43 - LYS A 44 MODEL 2 OMEGA = 147.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 36: PRO A 45 - SER A 46 MODEL 2 OMEGA = 145.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 37: VAL A 48 - THR A 49 MODEL 2 OMEGA = 5.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 38: THR A 49 - GLY A 50 MODEL 2 OMEGA = 143.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 39: GLY A 50 - TYR A 51 MODEL 2 OMEGA = 148.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 40: ASN A 53 - ASP A 54 MODEL 2 OMEGA = 12.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 41: ASP A 54 - ALA A 55 MODEL 2 OMEGA = 124.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 42: ALA A 55 - GLU A 56 MODEL 2 OMEGA = 99.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 43: ARG A 57 - LEU A 58 MODEL 2 OMEGA = 148.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 44: LEU A 58 - ALA A 59 MODEL 2 OMEGA = 148.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 45: ALA B 1 - ARG B 2 MODEL 2 OMEGA = 350.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 46: HIS B 6 - PHE B 7 MODEL 2 OMEGA = 116.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 47: PHE B 9 - ARG B 10 MODEL 2 OMEGA = 233.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 48: SER B 29 - MET B 30 MODEL 2 OMEGA = 216.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 49: ASN B 31 - SER B 32 MODEL 2 OMEGA = 144.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 50: VAL B 38 - GLN B 39 MODEL 2 OMEGA = 149.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 51: PRO B 45 - SER B 46 MODEL 2 OMEGA = 131.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 52: VAL B 48 - THR B 49 MODEL 2 OMEGA = 246.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 53: ASN B 53 - ASP B 54 MODEL 2 OMEGA = 14.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 54: ASP B 54 - ALA B 55 MODEL 2 OMEGA = 143.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 55: ALA B 55 - GLU B 56 MODEL 2 OMEGA = 89.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 56: LEU B 58 - ALA B 59 MODEL 2 OMEGA = 144.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 57: SER B 63 - GLU B 64 MODEL 2 OMEGA = 121.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 58: ASP A 3 - ASP A 4 MODEL 3 OMEGA = 39.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 59: HIS A 6 - PHE A 7 MODEL 3 OMEGA = 137.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 60: PHE A 9 - ARG A 10 MODEL 3 OMEGA = 130.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 61: SER A 29 - MET A 30 MODEL 3 OMEGA = 225.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 62: ASN A 31 - SER A 32 MODEL 3 OMEGA = 143.38 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 63: LYS A 44 - PRO A 45 MODEL 3 OMEGA = 47.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 64: GLY A 50 - TYR A 51 MODEL 3 OMEGA = 3.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 65: ARG A 52 - ASN A 53 MODEL 3 OMEGA = 211.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 66: ASN A 53 - ASP A 54 MODEL 3 OMEGA = 98.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 67: ASP A 54 - ALA A 55 MODEL 3 OMEGA = 111.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 68: ALA A 55 - GLU A 56 MODEL 3 OMEGA = 112.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 69: ARG A 57 - LEU A 58 MODEL 3 OMEGA = 143.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 70: LEU A 58 - ALA A 59 MODEL 3 OMEGA = 136.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 71: ASP A 60 - GLU A 61 MODEL 3 OMEGA = 145.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 72: GLU A 64 - LEU A 65 MODEL 3 OMEGA = 141.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 73: LEU A 65 - VAL A 66 MODEL 3 OMEGA = 210.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 74: ASP B 3 - ASP B 4 MODEL 3 OMEGA = 139.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 75: HIS B 6 - PHE B 7 MODEL 3 OMEGA = 120.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 76: PHE B 9 - ARG B 10 MODEL 3 OMEGA = 236.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 77: SER B 29 - MET B 30 MODEL 3 OMEGA = 222.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 78: ASN B 31 - SER B 32 MODEL 3 OMEGA = 145.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 79: PRO B 45 - SER B 46 MODEL 3 OMEGA = 145.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 80: VAL B 48 - THR B 49 MODEL 3 OMEGA = 2.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 81: GLY B 50 - TYR B 51 MODEL 3 OMEGA = 216.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 82: ASN B 53 - ASP B 54 MODEL 3 OMEGA = 345.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 83: ALA B 55 - GLU B 56 MODEL 3 OMEGA = 110.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 84: LEU B 58 - ALA B 59 MODEL 3 OMEGA = 135.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 85: HIS A 6 - PHE A 7 MODEL 4 OMEGA = 113.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 86: PHE A 9 - ARG A 10 MODEL 4 OMEGA = 240.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 87: SER A 29 - MET A 30 MODEL 4 OMEGA = 233.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 88: ASN A 31 - SER A 32 MODEL 4 OMEGA = 149.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 89: SER A 43 - LYS A 44 MODEL 4 OMEGA = 254.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 90: CIS PROLINE - PRO A 47 MODEL 4; 91: GLY A 50 - TYR A 51 MODEL 4 OMEGA = 349.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 92: TYR A 51 - ARG A 52 MODEL 4 OMEGA = 231.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 93: ASN A 53 - ASP A 54 MODEL 4 OMEGA = 261.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 94: ASP A 54 - ALA A 55 MODEL 4 OMEGA = 9.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 95: ALA A 55 - GLU A 56 MODEL 4 OMEGA = 100.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 96: ARG A 57 - LEU A 58 MODEL 4 OMEGA = 127.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 97: ASP A 60 - GLU A 61 MODEL 4 OMEGA = 149.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 98: SER A 63 - GLU A 64 MODEL 4 OMEGA = 101.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 99: ALA B 1 - ARG B 2 MODEL 4 OMEGA = 349.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 100: PHE B 9 - ARG B 10 MODEL 4 OMEGA = 348.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 101: SER B 29 - MET B 30 MODEL 4 OMEGA = 216.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 102: ASN B 31 - SER B 32 MODEL 4 OMEGA = 145.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 103: GLY B 50 - TYR B 51 MODEL 4 OMEGA = 148.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 104: ARG B 52 - ASN B 53 MODEL 4 OMEGA = 343.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 105: ASN B 53 - ASP B 54 MODEL 4 OMEGA = 353.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 106: ASP B 54 - ALA B 55 MODEL 4 OMEGA = 116.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 107: ALA B 55 - GLU B 56 MODEL 4 OMEGA = 123.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 108: LEU B 58 - ALA B 59 MODEL 4 OMEGA = 132.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 109: ASP B 60 - GLU B 61 MODEL 4 OMEGA = 138.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 110: GLN B 62 - SER B 63 MODEL 4 OMEGA = 69.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 111: SER B 63 - GLU B 64 MODEL 4 OMEGA = 245.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 112: GLU B 64 - LEU B 65 MODEL 4 OMEGA = 247.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 113: ALA A 1 - ARG A 2 MODEL 5 OMEGA = 351.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 114: HIS A 6 - PHE A 7 MODEL 5 OMEGA = 117.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 115: PHE A 9 - ARG A 10 MODEL 5 OMEGA = 243.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 116: MET A 11 - PRO A 12 MODEL 5 OMEGA = 133.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 117: SER A 29 - MET A 30 MODEL 5 OMEGA = 219.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 118: ASN A 31 - SER A 32 MODEL 5 OMEGA = 142.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 119: ASP A 40 - ALA A 41 MODEL 5 OMEGA = 210.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 120: ALA A 41 - LEU A 42 MODEL 5 OMEGA = 147.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 121: PRO A 45 - SER A 46 MODEL 5 OMEGA = 35.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 122: PRO A 47 - VAL A 48 MODEL 5 OMEGA = 30.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 123: THR A 49 - GLY A 50 MODEL 5 OMEGA = 212.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 124: GLY A 50 - TYR A 51 MODEL 5 OMEGA = 356.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 125: ARG A 52 - ASN A 53 MODEL 5 OMEGA = 131.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 126: ASP A 54 - ALA A 55 MODEL 5 OMEGA = 94.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 127: LEU A 58 - ALA A 59 MODEL 5 OMEGA = 146.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 128: SER A 63 - GLU A 64 MODEL 5 OMEGA = 110.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 129: ASP B 3 - ASP B 4 MODEL 5 OMEGA = 42.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 130: HIS B 6 - PHE B 7 MODEL 5 OMEGA = 144.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 131: PHE B 9 - ARG B 10 MODEL 5 OMEGA = 347.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 132: SER B 29 - MET B 30 MODEL 5 OMEGA = 219.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 133: ASN B 31 - SER B 32 MODEL 5 OMEGA = 144.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 134: PRO B 45 - SER B 46 MODEL 5 OMEGA = 114.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 135: ARG B 52 - ASN B 53 MODEL 5 OMEGA = 347.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 136: ASP B 54 - ALA B 55 MODEL 5 OMEGA = 108.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 137: LEU B 58 - ALA B 59 MODEL 5 OMEGA = 133.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 138: GLU B 64 - LEU B 65 MODEL 5 OMEGA = 144.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 139: HIS A 6 - PHE A 7 MODEL 6 OMEGA = 135.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 140: PHE A 9 - ARG A 10 MODEL 6 OMEGA = 350.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 141: SER A 29 - MET A 30 MODEL 6 OMEGA = 216.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 142: ASN A 31 - SER A 32 MODEL 6 OMEGA = 145.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 143: PRO A 45 - SER A 46 MODEL 6 OMEGA = 48.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 144: ARG A 52 - ASN A 53 MODEL 6 OMEGA = 22.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 145: ASN A 53 - ASP A 54 MODEL 6 OMEGA = 6.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 146: ASP A 54 - ALA A 55 MODEL 6 OMEGA = 125.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 147: ALA A 55 - GLU A 56 MODEL 6 OMEGA = 129.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 148: ARG A 57 - LEU A 58 MODEL 6 OMEGA = 144.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 149: LEU A 58 - ALA A 59 MODEL 6 OMEGA = 135.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 150: ALA A 59 - ASP A 60 MODEL 6 OMEGA = 138.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 151: SER A 63 - GLU A 64 MODEL 6 OMEGA = 133.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 152: ASP B 4 - PRO B 5 MODEL 6 OMEGA = 89.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 153: PRO B 5 - HIS B 6 MODEL 6 OMEGA = 210.60 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 154: HIS B 6 - PHE B 7 MODEL 6 OMEGA = 128.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 155: SER B 29 - MET B 30 MODEL 6 OMEGA = 215.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 156: ASN B 31 - SER B 32 MODEL 6 OMEGA = 148.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 157: ALA B 41 - LEU B 42 MODEL 6 OMEGA = 143.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 158: LYS B 44 - PRO B 45 MODEL 6 OMEGA = 223.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 159: PRO B 45 - SER B 46 MODEL 6 OMEGA = 120.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 160: VAL B 48 - THR B 49 MODEL 6 OMEGA = 11.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 161: GLY B 50 - TYR B 51 MODEL 6 OMEGA = 347.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 162: ASN B 53 - ASP B 54 MODEL 6 OMEGA = 135.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 163: ASP B 54 - ALA B 55 MODEL 6 OMEGA = 136.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 164: ALA B 55 - GLU B 56 MODEL 6 OMEGA = 113.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 165: LEU B 58 - ALA B 59 MODEL 6 OMEGA = 131.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 166: SER B 63 - GLU B 64 MODEL 6 OMEGA = 144.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 167: HIS A 6 - PHE A 7 MODEL 7 OMEGA = 115.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 168: PHE A 9 - ARG A 10 MODEL 7 OMEGA = 220.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 169: SER A 29 - MET A 30 MODEL 7 OMEGA = 222.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 170: ASN A 31 - SER A 32 MODEL 7 OMEGA = 143.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 171: GLN A 39 - ASP A 40 MODEL 7 OMEGA = 149.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 172: LEU A 42 - SER A 43 MODEL 7 OMEGA = 148.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 173: SER A 43 - LYS A 44 MODEL 7 OMEGA = 242.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 174: VAL A 48 - THR A 49 MODEL 7 OMEGA = 18.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 175: ARG A 52 - ASN A 53 MODEL 7 OMEGA = 341.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 176: ASP A 54 - ALA A 55 MODEL 7 OMEGA = 144.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 177: ALA A 55 - GLU A 56 MODEL 7 OMEGA = 113.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 178: LEU A 58 - ALA A 59 MODEL 7 OMEGA = 145.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 179: SER A 63 - GLU A 64 MODEL 7 OMEGA = 111.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 180: PHE B 9 - ARG B 10 MODEL 7 OMEGA = 340.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 181: SER B 29 - MET B 30 MODEL 7 OMEGA = 216.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 182: ASN B 31 - SER B 32 MODEL 7 OMEGA = 147.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 183: LEU B 42 - SER B 43 MODEL 7 OMEGA = 148.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 184: PRO B 45 - SER B 46 MODEL 7 OMEGA = 138.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 185: VAL B 48 - THR B 49 MODEL 7 OMEGA = 347.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 186: GLY B 50 - TYR B 51 MODEL 7 OMEGA = 4.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 187: ASN B 53 - ASP B 54 MODEL 7 OMEGA = 145.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 188: ASP B 54 - ALA B 55 MODEL 7 OMEGA = 141.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 189: ALA B 55 - GLU B 56 MODEL 7 OMEGA = 137.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 190: LEU B 58 - ALA B 59 MODEL 7 OMEGA = 120.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 191: SER B 63 - GLU B 64 MODEL 7 OMEGA = 123.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 192: ASP A 3 - ASP A 4 MODEL 8 OMEGA = 27.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 193: HIS A 6 - PHE A 7 MODEL 8 OMEGA = 135.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 194: PHE A 9 - ARG A 10 MODEL 8 OMEGA = 235.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 195: ARG A 16 - GLU A 17 MODEL 8 OMEGA = 119.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 196: ALA A 25 - ASN A 26 MODEL 8 OMEGA = 213.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 197: SER A 29 - MET A 30 MODEL 8 OMEGA = 220.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 198: ASN A 31 - SER A 32 MODEL 8 OMEGA = 147.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 199: SER A 43 - LYS A 44 MODEL 8 OMEGA = 234.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 200: LYS A 44 - PRO A 45 MODEL 8 OMEGA = 228.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 201: PRO A 45 - SER A 46 MODEL 8 OMEGA = 133.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 202: VAL A 48 - THR A 49 MODEL 8 OMEGA = 345.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 203: THR A 49 - GLY A 50 MODEL 8 OMEGA = 148.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 204: ASN A 53 - ASP A 54 MODEL 8 OMEGA = 345.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 205: ASP A 54 - ALA A 55 MODEL 8 OMEGA = 251.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 206: ALA A 55 - GLU A 56 MODEL 8 OMEGA = 90.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 207: ARG A 57 - LEU A 58 MODEL 8 OMEGA = 144.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 208: LEU A 58 - ALA A 59 MODEL 8 OMEGA = 148.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 209: SER A 63 - GLU A 64 MODEL 8 OMEGA = 109.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 210: HIS B 6 - PHE B 7 MODEL 8 OMEGA = 129.78 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 211: ARG B 10 - MET B 11 MODEL 8 OMEGA = 63.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 212: MET B 11 - PRO B 12 MODEL 8 OMEGA = 147.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 213: SER B 29 - MET B 30 MODEL 8 OMEGA = 224.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 214: ASN B 31 - SER B 32 MODEL 8 OMEGA = 145.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 215: PRO B 45 - SER B 46 MODEL 8 OMEGA = 141.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 216: VAL B 48 - THR B 49 MODEL 8 OMEGA = 337.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 217: ARG B 52 - ASN B 53 MODEL 8 OMEGA = 3.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 218: ASN B 53 - ASP B 54 MODEL 8 OMEGA = 211.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 219: ASP B 54 - ALA B 55 MODEL 8 OMEGA = 41.74 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 220: ALA B 55 - GLU B 56 MODEL 8 OMEGA = 139.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 221: ARG B 57 - LEU B 58 MODEL 8 OMEGA = 144.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 222: LEU B 58 - ALA B 59 MODEL 8 OMEGA = 131.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 223: ASP B 60 - GLU B 61 MODEL 8 OMEGA = 145.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 224: GLU B 64 - LEU B 65 MODEL 8 OMEGA = 143.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 225: PRO A 5 - HIS A 6 MODEL 9 OMEGA = 215.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 226: ASN A 8 - PHE A 9 MODEL 9 OMEGA = 147.28 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 227: PHE A 9 - ARG A 10 MODEL 9 OMEGA = 235.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 228: ARG A 10 - MET A 11 MODEL 9 OMEGA = 210.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 229: SER A 29 - MET A 30 MODEL 9 OMEGA = 213.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 230: ASN A 31 - SER A 32 MODEL 9 OMEGA = 143.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 231: LYS A 44 - PRO A 45 MODEL 9 OMEGA = 75.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 232: ASN A 53 - ASP A 54 MODEL 9 OMEGA = 230.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 233: ASP A 54 - ALA A 55 MODEL 9 OMEGA = 225.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 234: GLU A 56 - ARG A 57 MODEL 9 OMEGA = 264.42 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 235: LEU A 58 - ALA A 59 MODEL 9 OMEGA = 132.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 236: ASP A 60 - GLU A 61 MODEL 9 OMEGA = 116.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 237: SER A 63 - GLU A 64 MODEL 9 OMEGA = 104.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 238: ARG B 2 - ASP B 3 MODEL 9 OMEGA = 147.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 239: HIS B 6 - PHE B 7 MODEL 9 OMEGA = 147.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 240: PHE B 9 - ARG B 10 MODEL 9 OMEGA = 230.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 241: SER B 29 - MET B 30 MODEL 9 OMEGA = 220.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 242: ASN B 31 - SER B 32 MODEL 9 OMEGA = 146.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 243: SER B 43 - LYS B 44 MODEL 9 OMEGA = 145.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 244: CIS PROLINE - PRO B 47 MODEL 9; 245: PRO B 47 - VAL B 48 MODEL 9 OMEGA = 143.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 246: VAL B 48 - THR B 49 MODEL 9 OMEGA = 216.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 247: ASN B 53 - ASP B 54 MODEL 9 OMEGA = 293.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 248: ALA B 55 - GLU B 56 MODEL 9 OMEGA = 24.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 249: LEU B 58 - ALA B 59 MODEL 9 OMEGA = 147.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 250: ASP B 60 - GLU B 61 MODEL 9 OMEGA = 138.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 251: SER B 63 - GLU B 64 MODEL 9 OMEGA = 112.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 252: PHE A 9 - ARG A 10 MODEL 10 OMEGA = 342.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 253: SER A 29 - MET A 30 MODEL 10 OMEGA = 211.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 254: ASN A 31 - SER A 32 MODEL 10 OMEGA = 146.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 255: CIS PROLINE - PRO A 45 MODEL 10; 256: PRO A 45 - SER A 46 MODEL 10 OMEGA = 133.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 257: ASN A 53 - ASP A 54 MODEL 10 OMEGA = 146.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 258: ALA A 55 - GLU A 56 MODEL 10 OMEGA = 100.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 259: LEU A 58 - ALA A 59 MODEL 10 OMEGA = 132.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 260: PHE B 9 - ARG B 10 MODEL 10 OMEGA = 237.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 261: SER B 29 - MET B 30 MODEL 10 OMEGA = 213.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 262: PRO B 45 - SER B 46 MODEL 10 OMEGA = 137.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 263: ASN B 53 - ASP B 54 MODEL 10 OMEGA = 262.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 264: ASP B 54 - ALA B 55 MODEL 10 OMEGA = 229.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 265: ALA B 55 - GLU B 56 MODEL 10 OMEGA = 92.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 266: LEU B 58 - ALA B 59 MODEL 10 OMEGA = 142.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 267: SER B 63 - GLU B 64 MODEL 10 OMEGA = 94.58 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 268: GLU B 64 - LEU B 65 MODEL 10 OMEGA = 214.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 269: LEU B 65 - VAL B 66 MODEL 10 OMEGA = 146.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 270: HIS A 6 - PHE A 7 MODEL 11 OMEGA = 142.63 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 271: SER A 29 - MET A 30 MODEL 11 OMEGA = 221.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 272: ASN A 31 - SER A 32 MODEL 11 OMEGA = 143.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 273: PRO A 45 - SER A 46 MODEL 11 OMEGA = 130.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 274: ARG A 52 - ASN A 53 MODEL 11 OMEGA = 33.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 275: ASN A 53 - ASP A 54 MODEL 11 OMEGA = 140.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 276: ASP A 54 - ALA A 55 MODEL 11 OMEGA = 140.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 277: ALA A 55 - GLU A 56 MODEL 11 OMEGA = 129.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 278: LEU A 58 - ALA A 59 MODEL 11 OMEGA = 139.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 279: ALA A 59 - ASP A 60 MODEL 11 OMEGA = 141.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 280: ASP A 60 - GLU A 61 MODEL 11 OMEGA = 129.99 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 281: GLU A 64 - LEU A 65 MODEL 11 OMEGA = 148.73 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 282: PHE B 9 - ARG B 10 MODEL 11 OMEGA = 229.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 283: PRO B 12 - MET B 13 MODEL 11 OMEGA = 213.34 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 284: SER B 29 - MET B 30 MODEL 11 OMEGA = 215.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 285: ASN B 31 - SER B 32 MODEL 11 OMEGA = 148.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 286: VAL B 38 - GLN B 39 MODEL 11 OMEGA = 149.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 287: CIS PROLINE - PRO B 47 MODEL 11; 288: PRO B 47 - VAL B 48 MODEL 11 OMEGA = 141.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 289: GLY B 50 - TYR B 51 MODEL 11 OMEGA = 343.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 290: ASN B 53 - ASP B 54 MODEL 11 OMEGA = 12.37 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 291: ALA B 55 - GLU B 56 MODEL 11 OMEGA = 94.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 292: LEU B 58 - ALA B 59 MODEL 11 OMEGA = 137.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 293: SER B 63 - GLU B 64 MODEL 11 OMEGA = 121.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 294: LEU B 65 - VAL B 66 MODEL 11 OMEGA = 143.68 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 295: HIS A 6 - PHE A 7 MODEL 12 OMEGA = 146.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 296: PHE A 9 - ARG A 10 MODEL 12 OMEGA = 213.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 297: ARG A 10 - MET A 11 MODEL 12 OMEGA = 211.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 298: ASN A 31 - SER A 32 MODEL 12 OMEGA = 142.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 299: LYS A 44 - PRO A 45 MODEL 12 OMEGA = 220.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 300: PRO A 45 - SER A 46 MODEL 12 OMEGA = 128.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 301: ASN A 53 - ASP A 54 MODEL 12 OMEGA = 3.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 302: ALA A 55 - GLU A 56 MODEL 12 OMEGA = 107.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 303: LEU A 58 - ALA A 59 MODEL 12 OMEGA = 138.61 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 304: PRO B 5 - HIS B 6 MODEL 12 OMEGA = 210.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 305: PHE B 9 - ARG B 10 MODEL 12 OMEGA = 212.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 306: SER B 29 - MET B 30 MODEL 12 OMEGA = 212.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 307: ASN B 31 - SER B 32 MODEL 12 OMEGA = 144.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 308: LEU B 42 - SER B 43 MODEL 12 OMEGA = 107.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 309: VAL B 48 - THR B 49 MODEL 12 OMEGA = 346.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 310: ASN B 53 - ASP B 54 MODEL 12 OMEGA = 148.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 311: ASP B 54 - ALA B 55 MODEL 12 OMEGA = 83.47 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 312: ALA B 55 - GLU B 56 MODEL 12 OMEGA = 148.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 313: LEU B 58 - ALA B 59 MODEL 12 OMEGA = 141.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 314: ASP B 60 - GLU B 61 MODEL 12 OMEGA = 145.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 315: SER B 63 - GLU B 64 MODEL 12 OMEGA = 125.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 316: HIS A 6 - PHE A 7 MODEL 13 OMEGA = 144.66 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 317: PHE A 9 - ARG A 10 MODEL 13 OMEGA = 217.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 318: SER A 29 - MET A 30 MODEL 13 OMEGA = 215.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 319: ASN A 31 - SER A 32 MODEL 13 OMEGA = 148.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 320: SER A 43 - LYS A 44 MODEL 13 OMEGA = 238.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 321: ASN A 53 - ASP A 54 MODEL 13 OMEGA = 115.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 322: LEU A 58 - ALA A 59 MODEL 13 OMEGA = 148.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 323: ALA A 59 - ASP A 60 MODEL 13 OMEGA = 144.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 324: ASP A 60 - GLU A 61 MODEL 13 OMEGA = 91.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 325: GLU A 61 - GLN A 62 MODEL 13 OMEGA = 102.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 326: SER A 63 - GLU A 64 MODEL 13 OMEGA = 106.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 327: HIS B 6 - PHE B 7 MODEL 13 OMEGA = 146.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 328: PHE B 9 - ARG B 10 MODEL 13 OMEGA = 224.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 329: SER B 29 - MET B 30 MODEL 13 OMEGA = 218.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 330: LYS B 44 - PRO B 45 MODEL 13 OMEGA = 218.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 331: PRO B 45 - SER B 46 MODEL 13 OMEGA = 141.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 332: VAL B 48 - THR B 49 MODEL 13 OMEGA = 227.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 333: GLY B 50 - TYR B 51 MODEL 13 OMEGA = 22.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 334: ASP B 54 - ALA B 55 MODEL 13 OMEGA = 232.67 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 335: ALA B 55 - GLU B 56 MODEL 13 OMEGA = 123.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 336: LEU B 58 - ALA B 59 MODEL 13 OMEGA = 127.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 337: ASP B 60 - GLU B 61 MODEL 13 OMEGA = 129.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 338: GLU B 64 - LEU B 65 MODEL 13 OMEGA = 147.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 339: PHE A 9 - ARG A 10 MODEL 14 OMEGA = 218.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 340: SER A 29 - MET A 30 MODEL 14 OMEGA = 213.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 341: ASN A 31 - SER A 32 MODEL 14 OMEGA = 145.57 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 342: LYS A 44 - PRO A 45 MODEL 14 OMEGA = 237.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 343: PRO A 45 - SER A 46 MODEL 14 OMEGA = 127.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 344: VAL A 48 - THR A 49 MODEL 14 OMEGA = 210.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 345: ASN A 53 - ASP A 54 MODEL 14 OMEGA = 226.36 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 346: ASP A 54 - ALA A 55 MODEL 14 OMEGA = 284.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 347: GLU A 56 - ARG A 57 MODEL 14 OMEGA = 254.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 348: ARG A 57 - LEU A 58 MODEL 14 OMEGA = 301.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 349: ALA A 59 - ASP A 60 MODEL 14 OMEGA = 219.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 350: ASP A 60 - GLU A 61 MODEL 14 OMEGA = 221.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 351: GLU A 61 - GLN A 62 MODEL 14 OMEGA = 86.30 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 352: SER A 63 - GLU A 64 MODEL 14 OMEGA = 44.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 353: PRO B 12 - MET B 13 MODEL 14 OMEGA = 210.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 354: ASN B 26 - GLY B 27 MODEL 14 OMEGA = 211.75 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 355: SER B 29 - MET B 30 MODEL 14 OMEGA = 213.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 356: ASN B 31 - SER B 32 MODEL 14 OMEGA = 145.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 357: LYS B 44 - PRO B 45 MODEL 14 OMEGA = 137.76 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 358: CIS PROLINE - PRO B 47 MODEL 14; 359: GLY B 50 - TYR B 51 MODEL 14 OMEGA = 0.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 360: ASP B 54 - ALA B 55 MODEL 14 OMEGA = 62.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 361: GLU B 56 - ARG B 57 MODEL 14 OMEGA = 111.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 362: ARG B 57 - LEU B 58 MODEL 14 OMEGA = 216.16 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 363: LEU B 58 - ALA B 59 MODEL 14 OMEGA = 123.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 364: ALA B 59 - ASP B 60 MODEL 14 OMEGA = 216.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 365: ASP B 60 - GLU B 61 MODEL 14 OMEGA = 257.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 366: GLN B 62 - SER B 63 MODEL 14 OMEGA = 273.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 367: SER B 63 - GLU B 64 MODEL 14 OMEGA = 119.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 368: GLU B 64 - LEU B 65 MODEL 14 OMEGA = 146.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 369: HIS A 6 - PHE A 7 MODEL 15 OMEGA = 147.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 370: ARG A 10 - MET A 11 MODEL 15 OMEGA = 217.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 371: SER A 29 - MET A 30 MODEL 15 OMEGA = 213.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 372: ASN A 31 - SER A 32 MODEL 15 OMEGA = 145.41 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 373: LYS A 44 - PRO A 45 MODEL 15 OMEGA = 211.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 374: PRO A 45 - SER A 46 MODEL 15 OMEGA = 134.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 375: VAL A 48 - THR A 49 MODEL 15 OMEGA = 232.51 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 376: GLY A 50 - TYR A 51 MODEL 15 OMEGA = 358.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 377: ASN A 53 - ASP A 54 MODEL 15 OMEGA = 357.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 378: ALA A 55 - GLU A 56 MODEL 15 OMEGA = 121.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 379: LEU A 58 - ALA A 59 MODEL 15 OMEGA = 117.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 380: ASP A 60 - GLU A 61 MODEL 15 OMEGA = 133.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 381: GLU A 61 - GLN A 62 MODEL 15 OMEGA = 145.31 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 382: SER A 63 - GLU A 64 MODEL 15 OMEGA = 143.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 383: GLU A 64 - LEU A 65 MODEL 15 OMEGA = 148.38 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 384: HIS B 6 - PHE B 7 MODEL 15 OMEGA = 149.17 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 385: PHE B 9 - ARG B 10 MODEL 15 OMEGA = 236.01 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 386: LYS B 20 - PHE B 21 MODEL 15 OMEGA = 148.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 387: SER B 29 - MET B 30 MODEL 15 OMEGA = 218.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 388: ASN B 31 - SER B 32 MODEL 15 OMEGA = 149.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 389: LYS B 44 - PRO B 45 MODEL 15 OMEGA = 143.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 390: TYR B 51 - ARG B 52 MODEL 15 OMEGA = 149.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 391: ARG B 52 - ASN B 53 MODEL 15 OMEGA = 16.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 392: ASP B 54 - ALA B 55 MODEL 15 OMEGA = 142.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 393: ALA B 55 - GLU B 56 MODEL 15 OMEGA = 120.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 394: LEU B 58 - ALA B 59 MODEL 15 OMEGA = 143.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION; 395: SER B 63 - GLU B 64 MODEL 15 OMEGA = 77.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION

NMR ensembles

	Data	Criteria
Number of conformers (submitted / calculated)	15 / -
Representative

Components

#1: Protein

A B MNT REPRESSOR

Details:

Mass: 8826.000 Da / Num. of mol.: 2
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Enterobacteria phage P22 (virus) / Genus: P22-like viruses / References: UniProt: P03049

Experimental details

Experiment

• Experiment: Method: SOLUTION NMR

Sample preparation

• Crystal grow: Method: other / Details: NMR

Processing

• NMR ensemble: Conformers submitted total number: 15